MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in MiNK Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −7 vs. Q2 2023
- Shares held
- 723.5K
- −751.9K (−51.0%) vs. Q2 2023
- Total value
- $800.0K
- −$2.29M (−74.1%) vs. Q2 2023
- New holders
- 1
- 7 more added
- Sold out
- 8
- 17 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 5 | $6 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 10 | $11 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 14 | $15 | 0.00% | −12−46.2% | Reduced |
| Signaturefd, LLC | 18 | $20 | 0.00% | −46−71.9% | Reduced |
| Key Financial Inc | 43 | $47 | 0.00% | 00.0% | Unchanged |
| Sittner & Nelson, LLC | 58 | $64 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 60 | $70 | 0.00% | −9,434−99.4% | Reduced |
| Quadrant Capital Group LLC | 72 | $80 | 0.00% | −96−57.1% | Reduced |
| JPMorgan Chase & Co | 107 | $125 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 185 | $204 | 0.00% | 00.0% | Unchanged |
| Chilton Capital Management LLC | 309 | $340 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 402 | $440 | 0.00% | +49+13.9% | Added |
| Lazard Asset Management LLC | 1,294 | $1.00K | 0.00% | +104+8.7% | Added |
| Royal Bank of Canada | 649 | $1.00K | 0.00% | +111+20.6% | Added |
| Covestor Ltd | 1,078 | $1.00K | 0.00% | +494+84.6% | Added |
| Artal Group S.A. | 1,916 | $2.00K | 0.00% | −226,300−99.2% | Reduced |
| Qube Research & Technologies Ltd | 1,941 | $2.27K | 0.00% | +1,941 | New |
| UBS Group AG | 3,547 | $3.90K | 0.00% | +397+12.6% | Added |
| California State Teachers Retirement System | 5,066 | $5.93K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,695 | $8.46K | 0.00% | −3,454−31.0% | Reduced |
| Morgan Stanley | 8,097 | $8.91K | 0.00% | −4,090−33.6% | Reduced |
| Northern Trust Corp | 11,125 | $12.2K | 0.00% | −20.0% | Reduced |
| HighTower Advisors, LLC | 16,413 | $13.0K | 0.00% | −562−3.3% | Reduced |
| Wells Fargo & Company | 12,125 | $13.3K | 0.00% | −15,298−55.8% | Reduced |
| Goldman Sachs Group Inc | 17,312 | $19.0K | 0.00% | +298+1.8% | Added |
| UBS Oconnor LLC | 21,590 | $25.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 25,402 | $27.9K | 0.00% | −953−3.6% | Reduced |
| State Street Corp | 25,700 | $30.1K | 0.00% | −3,073−10.7% | Reduced |
| Oracle Investment Management Inc | 36,898 | $40.6K | 0.06% | −13,563−26.9% | Reduced |
| Renaissance Technologies LLC | 57,704 | $63.0K | 0.00% | −87,824−60.3% | Reduced |
| Captrust Financial Advisors | 61,799 | $68.0K | 0.00% | +22,257+56.3% | Added |
| BlackRock Inc. | 80,499 | $88.5K | 0.00% | −1,530−1.9% | Reduced |
| Geode Capital Management, LLC | 90,164 | $105.5K | 0.00% | −2,559−2.8% | Reduced |
| Vanguard Group Inc | 234,182 | $257.6K | 0.00% | −7,001−2.9% | Reduced |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −324,867−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −51,048−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,232−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,544−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| First Command Bank | – | – | – | – | Not filed |
| First Command Financial Services, Inc. | – | – | – | – | Not filed |